Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells among those with lung cancer. Antibody-drug conjugates like Datroway ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

What is Keytruda and how does it work? Experts explain the cancer immunotherapy as a global investigation raises concerns ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

Varun Venkataramani is the winner of the 2025 Eppendorf Award for Young European Investigators. A neurologist and group leader at Heidelberg University Hospital, Germany, his work in cancer ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

A vaccine combined with Keytruda is associated with a 49% reduction in the risk of recurrence or death. Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer ...

New study shows that aggressive cancer cells can be identified in a simple, new way; by how they physically behave, not just by their genes. Using specially textured Meta surfaces pattered with tiny ...

Researchers at Oregon Health & Science University have identified a previously unknown system inside cells that works like ...

The research, published today in Nature Communications, focuses on how cancer cells keep their chromosomes intact so they can continue dividing relentlessly. Normally, every time a cell divides, the ...